Primitive liver cancers: Epidemiology and geographical study in France

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 9, 2009, Pages 984-989

  Borie, Frédéric ^a,b   Trétarre, Brigitte ^a   Bouvier, Anne Marie ^c   Faivre, Jean ^c   Binder, Florence ^c   Launoy, Guy ^c   Delafosse, Patricia ^c   Tissot, Jacques ^c   Peng, Jun ^c   Grosclaude, Pascale ^c   Guizard, Anne Valérie ^c   Gras Aygon, Claudine ^a  

^a Centre de Recherche   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c Registre Digestif de la Côte d'Or ^*  (France)

Author keywords

Cancer registries; Cirrhosis; Epidemiology; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Primary liver cancer

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; FEMALE; FRANCE; GEOGRAPHY; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; VIRAL CONTAMINATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; FRANCE; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; REGISTRIES; RISK FACTORS;

EID: 69549131385     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283293783     Document Type: Article

References (24)

1. Parkin DM, Whelan SL, Ferlay J, Parkin DM. Cancer Incidence in Five Continents, Vol VIII. IARC Scientific Publication No 1555. 2003. International Agency for Research on Cancer, Lyon.
2. Globocan 2002 date base. International Agency for Research on Cancer http://www-dep.iarc.fr
3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127 (5 Suppl 1):S5-S16. (Pubitemid 39423365)
4. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: an Update. Ann Intern Med 2003; 139:817-823.
5. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127 (5 Suppl 1):S27-S34. (Pubitemid 39423367)
6. Lepage C, Remontet L, Launoy G, Trétarre B, Grosclaude P, Colonna M, et al. French network of cancer registries (FRANCIM). Trends in incidence of digestive cancers in France. Eur J Cancer Prev 2008; 17:13-17
7. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51:3-30.
8. Reynaud M, Le Breton P, Gilot B, Vervialle F, Falissard B. Alcohol is the main factor in excess traffic accident fatalities in France. Alcohol Clin Exp Res 2002; 26 (12): 1833-1839. (Pubitemid 36008620)
9. Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 2003; 39:2087-2092. (Pubitemid 37297766)
10. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40:472-477. (Pubitemid 38230849)
11. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24:115-125.
12. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128:620-626. (Pubitemid 40585364)
13. Bosch FX, Ribes J. Epidemiology of liver cancer in Europe. Can J Gastroenterol 2000; 14:621-630.
14. Michielsen PP, Francque SM, Van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Onc 2005; 3:27-45.
15. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127:1372-1380. (Pubitemid 39457763)
16. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160:3227-3230.
17. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35 (5 Suppl 2):S72-S78.
18. Benhamiche AM, Faivre C, Minello A, Clinard F, Mitry E, Hillon P, Faivre J. Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J Hepatol 1998; 29:802-806.
19. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9:191-211.
20. Antona D, Delarocque-Astagneau E, Lévy-Bruhl D. Obligatory declaration of hepatitis B: results of the first year of surveillance in France. Bul Epidemio Hebd 2005; 31:157-160.
21. Pol S, Zylberberg H. Clinical forms and prognosis of hepatitis C. Revue du Praticien 2000; 50:1083-1087.
22. Desenclos JC. Epidemiology of hepatitis C. Revue du Praticien 2000; 50:1066-1070.
23. Rosmorduc O, Paterlini P, Poupon R, Brechot C. Hepatitis virus and hepatocellular carcinoma. Gastroenterol Clin Biol 1999; 23:363-375.
24. Even C, Launoy G, Collet T, Duval O, Piquet MA, Rougereau A, et al. Epidemiology of hepatocellular carcinoma in the department of Calvados. Gastroenterol Clin Biol 1997; 21:450-458. (Pubitemid 27323640)